JPWO2022250155A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022250155A5 JPWO2022250155A5 JP2023524257A JP2023524257A JPWO2022250155A5 JP WO2022250155 A5 JPWO2022250155 A5 JP WO2022250155A5 JP 2023524257 A JP2023524257 A JP 2023524257A JP 2023524257 A JP2023524257 A JP 2023524257A JP WO2022250155 A5 JPWO2022250155 A5 JP WO2022250155A5
- Authority
- JP
- Japan
- Prior art keywords
- oligonucleotide
- bond
- base sequence
- seq
- pharma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021090359 | 2021-05-28 | ||
| PCT/JP2022/021818 WO2022250155A1 (ja) | 2021-05-28 | 2022-05-27 | アンチセンス核酸 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022250155A1 JPWO2022250155A1 (https=) | 2022-12-01 |
| JPWO2022250155A5 true JPWO2022250155A5 (https=) | 2025-05-27 |
Family
ID=84228935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023524257A Pending JPWO2022250155A1 (https=) | 2021-05-28 | 2022-05-27 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250084411A1 (https=) |
| EP (1) | EP4349987A1 (https=) |
| JP (1) | JPWO2022250155A1 (https=) |
| KR (1) | KR20240013202A (https=) |
| CN (1) | CN117500925A (https=) |
| AU (1) | AU2022279820A1 (https=) |
| CA (1) | CA3221758A1 (https=) |
| MX (1) | MX2023014092A (https=) |
| TW (1) | TW202313975A (https=) |
| WO (1) | WO2022250155A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117321205A (zh) * | 2021-05-13 | 2023-12-29 | 国立大学法人千叶大学 | 反义寡聚物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU655164B2 (en) | 1989-12-20 | 1994-12-08 | Antivirals Inc. | Uncharged morpholino-based polymers having phosphorous-containing chiral intersubunit linkages |
| RU2606627C2 (ru) | 2007-11-15 | 2017-01-10 | Серепта Терапьютикс,Инк. | Способ синтеза морфолиновых олигомеров |
| BR122020021379B1 (pt) * | 2008-10-24 | 2021-05-11 | Sarepta Therapeutics, Inc. | oligômero morfolino fosforodiamidato, composição que compreende o mesmo e uso do dito oligômero para tratar distrofia muscular |
| CA2778171C (en) | 2009-10-29 | 2017-07-25 | Osaka University | Bridged artificial nucleoside and nucleotide |
| KR101707437B1 (ko) | 2012-09-21 | 2017-02-16 | 고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 | 구아니딘 가교를 갖는 인공 뉴클레오시드 및 올리고뉴클레오티드 |
| CN106103463B (zh) | 2014-02-18 | 2018-11-30 | 国立大学法人大阪大学 | 桥连型核苷和核苷酸 |
-
2022
- 2022-05-27 TW TW111119953A patent/TW202313975A/zh unknown
- 2022-05-27 EP EP22811423.7A patent/EP4349987A1/en not_active Withdrawn
- 2022-05-27 CN CN202280038163.1A patent/CN117500925A/zh active Pending
- 2022-05-27 AU AU2022279820A patent/AU2022279820A1/en active Pending
- 2022-05-27 US US18/564,976 patent/US20250084411A1/en active Pending
- 2022-05-27 CA CA3221758A patent/CA3221758A1/en active Pending
- 2022-05-27 MX MX2023014092A patent/MX2023014092A/es unknown
- 2022-05-27 KR KR1020237044656A patent/KR20240013202A/ko active Pending
- 2022-05-27 JP JP2023524257A patent/JPWO2022250155A1/ja active Pending
- 2022-05-27 WO PCT/JP2022/021818 patent/WO2022250155A1/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6647430B2 (ja) | アンチセンス核酸 | |
| JP4383720B2 (ja) | オリゴヌクレオチドｎ３’→ｐ５’ホスホルアミデート：合成および化合物；ハイブリダイゼーションおよびヌクレアーゼ耐性特性 | |
| JP2024023899A (ja) | アンチセンス核酸 | |
| JP6382150B2 (ja) | ｍＲＮＡ前駆体のスプライシングを修飾するＥＮＡ核酸医薬 | |
| US5596091A (en) | Antisense oligonucleotides comprising 5-aminoalkyl pyrimidine nucleotides | |
| US7138383B2 (en) | Treating cancer using an oligonucleotide N3′->N5′ thiophosphoramidate | |
| KR102071729B1 (ko) | 안티센스 핵산 | |
| JP2024038104A (ja) | アンチセンス核酸 | |
| JP7348922B2 (ja) | Ｂ型肝炎感染の治療用のＰＡＰＤ５及びＰＡＰＤ７ ｍＲＮＡを低減させるための核酸分子 | |
| US11261440B2 (en) | Antisense oligonucleic acid | |
| CA2817002C (en) | Base modified oligonucleotides | |
| JP2005522997A (ja) | 交代セグメントを含むオリゴヌクレオチド及びその用途 | |
| Peyrottes et al. | Oligodeoxynucleoside phosphoramidates (P-NH 2): Synthesis and thermal stability of duplexes with DNA and RNA targets | |
| JPH07501527A (ja) | 修飾されたピリミジンを含有するオリゴマーを使用する増強された三重らせんおよび二重らせんの成形 | |
| WO1992010590A1 (en) | Inhibition of transcription by formation of triple helixes | |
| KR20110017005A (ko) | Ｔｇｆ-베타 수용체 유전자 발현 억제용 조성물 및 방법 | |
| CN104321334A (zh) | 三环核苷及由其制备的低聚化合物 | |
| Koch et al. | Locked nucleic acid | |
| JPWO2022250155A5 (https=) | ||
| JP2000512630A (ja) | ２’―置換ヌクレオシドおよびオリゴヌクレオチド誘導体 | |
| Benhida et al. | Incorporation of serinol derived acyclic nucleoside analogues into oligonucleotides: influence on duplex and triplex formation | |
| CN118019848A (zh) | Rna编辑 | |
| HU218086B (hu) | Aminosavat tartalmazó nukleotid monomer analógok | |
| JPH1135595A (ja) | アンチセンスオリゴヌクレオチド及びそれを用いた制癌剤 | |
| RU2025110470A (ru) | КОМПОЗИЦИИ миРНК И СПОСОБЫ ДЛЯ НАЦЕЛИВАНИЯ НА НУКЛЕИНОВЫЕ КИСЛОТЫ БЕЛКА ТАУ, АССОЦИИРОВАННОГО С МИКРОТРУБОЧКАМИ |